by | Jan 5, 2026 | Dai, Yifan, Pappu, Rohit
— Published date: 1/6/2025
Value Proposition: Directed evolution of synthetic intrinsically disordered proteins for condensate editing.
Technology Description
Researchers at Washington University in St. Louis have developed a directed evolution method and selection strategies to enable the evolut…
by | Jan 5, 2026 | Boon, Adrianus "Jacco", Dai, Yanan, Fremont, Daved, Harastani, Houda
— Published date: 1/6/2025
Value Proposition: Stabilization of glycoprotein of Bourbon Virus (BRBV) and related thogotoviruses as a key target for vaccine and antiviral development.
Technology Description
Researchers at Washington University in St. Louis have determined the pre-fusion structure…
by | May 14, 2025 | DiPersio, John, Ghobadi, Armin, O'Neal, Julie, Ritchey, Julie
— Published Date: 5/13/2025
Value Proposition: An innovative therapy leveraging unique chimeric antigen receptors (CAR) to specifically target Fc receptor-like 5 (FCRL5), enabling the precise elimination of FCRL5-expressing cells to treat multiple myeloma and other cancers.
Technology Description
…
by | May 12, 2025 | Beric, Aleksandra, Ibanez, Laura
— Published Date: 5/13/2025
Value Proposition: Plasma cell-free transcripts that can be used as biomarkers to aid in the diagnosis and monitoring of Parkinsons Disease.
Technology Description
Researchers at Washington University in St. Louis have developed a panel of cell free RNA (cfRNA) biomark…
by | May 9, 2025 | Cisterna Garcia, Alejandro, Cruchaga, Carlos, Ibanez, Laura
— Published Date: 5/10/2025
Value Proposition: Method that uses plasma cfRNAs to differentiate Alzheimer’s disease from healthy controls.
Technology Description
Researchers at Washington University in St. Louis have developed a series of models using blood-based biomarkers to detect Alzheimer&…